Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

precision medicine

Advancing Precision Medicine in Oncology

Jerome Madison, Host of The Precision Medicine Podcast, shares his leadership lessons and tips for building and training new sales teams in the era of precision medicine. He also dives...

Impetus Digital

- PMLiVE

MIT researchers develop AI model to detect Parkinson’s from breathing patterns

The tool uses a series of connected algorithms that can assess if someone has PD from their nocturnal breathing

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

Impetus Digital

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

Impetus Digital

- PMLiVE

FDA approves Bot Image’s AI software for the detection and diagnosis of prostate cancer

ProstateID combines artificial intelligence with traditional MRI scanning to significantly improve radiologic interpretation accuracy

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Impetus Digital

- PMLiVE

6 trends shaping the future of personalized medicine

Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators.

Avalere Health

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Impetus Digital

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Impetus Digital

- PMLiVE

Gilead invests $85m in Gilead Foundation towards health equity progress

The donation follows an endowment announced by the company in 2021 to recapitalise the Foundation

- PMLiVE

Bristol Myers Squibb launches initiative to ensure disability diversity in clinical trials

Current common clinical trial practices exclude up to a quarter of the US population based on disability status

COS and Genesis Research

Genesis Research and Clinical Outcomes Solutions announce innovative partnership

International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes...

Genesis Research Group

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links